|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01833 PA GOODDOCTOR
Nominal 
6.300 -0.400 (-5.970%) Ranking Overview
Ranking based on 7 research report(s)
Average Ranking 2.43
|
Strong Buy (1)
0
|
Buy (2)
4
|
Hold (3)
3
|
Sell (4)
0
|
Strong Sell (5)
0
|
Previous Financial Performance
| Financial Year | 12/2023 | EPS | -30.00 RMB (cts) | |
| Net Profit | -322.59 RMB (MIL) | DPS | 0.00 RMB (cts) |
Consolidation Estimation
| Financial Year | Profit / (Loss) (RMB (MIL)) |
EPS/ ((LPS)(RMB (cts)) |
DPS (RMB (cts)) |
Net Asset Value per Share (RMB) |
Highest (RMB (MIL)) |
Lowest (RMB (MIL)) |
| 2024 | 145.60 | 13.00 | 0 | -- | 188.78 | 56.00 |
| 2025 | 205.00 | 20.00 | 0 | -- | 267.35 | 117.00 |
| 2026 | 276.00 | 33.00 | 0 | -- | 400.00 | 181.00 |
Profit Estimation
| Profit Estimation | Profit / (Loss) (RMB (MIL)) |
EPS*/ (LPS) (RMB (cts)) |
DPS * (RMB (cts)) |
Broker | Ranking | Target Price* (HKD) |
Update Date | |
| 2024 | 145.60 | 19.70 | -- | UOB | Buy | 17.00 | 14/10/2024 | |
| 2024 | 188.78 | 17.00 | -- | HUATAI FIN HLDGS HK | Buy | 15.30 | 21/08/2024 | |
| 2024 | 120.00 | 11.00 | -- | CLSA | OutPerform | 14.70 | 15/11/2024 | |
| 2024 | 56.00 | 14.00 | -- | CCBI | OutPerform | 13.50 | 21/08/2024 | |
| 2024 | 149.00 | 13.00 | -- | MORGAN STANLEY | Equal-weight | 12.50 | 05/11/2024 | |
| 2024 | 89.00 | 8.00 | -- | HSBC | Hold | 11.50 | 21/08/2024 | |
| 2024 | 157.00 | 10.00 | -- | SPDB INT'L SEC | Hold | 11.40 | 22/08/2024 | |
| 2025 | 238.80 | 29.20 | -- | UOB | -- | -- | 14/10/2024 | |
| 2025 | 267.35 | 25.00 | -- | HUATAI FIN HLDGS HK | -- | -- | 21/08/2024 | |
| 2025 | 150.00 | 13.00 | -- | CLSA | -- | -- | 15/11/2024 | |
| 2025 | 117.00 | 22.00 | -- | CCBI | -- | -- | 21/08/2024 | |
| 2025 | 205.00 | 18.00 | -- | MORGAN STANLEY | -- | -- | 05/11/2024 | |
| 2025 | 183.00 | 16.00 | -- | HSBC | -- | -- | 21/08/2024 | |
| 2025 | 252.00 | 20.00 | -- | SPDB INT'L SEC | -- | -- | 22/08/2024 | |
| 2026 | 378.10 | 43.20 | -- | UOB | -- | -- | 14/10/2024 | |
| 2026 | 353.12 | 33.00 | -- | HUATAI FIN HLDGS HK | -- | -- | 21/08/2024 | |
| 2026 | 181.00 | 16.00 | -- | CLSA | -- | -- | 15/11/2024 | |
| 2026 | 222.00 | 34.00 | -- | CCBI | -- | -- | 21/08/2024 | |
| 2026 | 276.00 | 25.00 | -- | MORGAN STANLEY | -- | -- | 05/11/2024 | |
| 2026 | 226.00 | 20.00 | -- | HSBC | -- | -- | 21/08/2024 | |
| 2026 | 400.00 | 40.00 | -- | SPDB INT'L SEC | -- | -- | 22/08/2024 | |
| Remarks: | Average rating ranges from 1 to 5. The lower the figure, the higher the rating and the vice versa. |
| *EPS, DPS and Estimated Price would be adjusted upon Consolidation, Split and Bonus Issue | |
| Real time quote last updated: 30/12/2024 16:35 | |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 56,648 |
| %Change | -- |
| EPS / (LPS) | RMB 0.050 |
| NBV Per Share (¥) | RMB 11.958 |